NRD
DGX icon

Nebula Research & Development’s Quest Diagnostics DGX Stock Holding History

Nebula Research & Development’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-8,853
Closed -$1.59M – 254
2025
Q2 		$1.59M Buy
+8,853
New +$1.54M 0.14% 248
2024
Q4 		– Sell
-10,293
Closed -$1.6M – 949
2024
Q3 		$1.6M Buy
+10,293
New +$1.54M 0.19% 144

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Nebula Research & Development's DGX Position: Q3 2025 in Review

Nebula Research & Development sold out of Quest Diagnostics (DGX) in Q3 2025, closing a stake of 8,853 shares — an estimated $1.59M sold.

Nebula Research & Development first reported a position in DGX in Q3 2024 and held it in 2 quarters. The position peaked at $1.6M in Q3 2024. 1,006 funds tracked by Wall St. Rank hold DGX as of Q3 2025.

  • Nebula Research & Development reported no remaining Quest Diagnostics position as of Q3 2025 after selling out during the quarter.
  • Nebula Research & Development sold 8,853 Quest Diagnostics shares in Q3 2025, an estimated $1.59M.
  • Nebula Research & Development first reported a position in Quest Diagnostics in Q3 2024 and held it in 2 quarters.
  • Nebula Research & Development's Quest Diagnostics position peaked at $1.6M in Q3 2024.
  • 1,006 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2025.

Based on Nebula Research & Development's 13F filing for Q3 2025.